Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline
for diagnosis, treatment and follow-up

J 2025

Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

RESTEGHINI, C.; B. BAUJAT; P. BOSSI; A. FRANCHI; L. DE GABORY et. al.

Basic information

Original name

Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

Authors

RESTEGHINI, C.; B. BAUJAT; P. BOSSI; A. FRANCHI; L. DE GABORY; Jana HALÁMKOVÁ (203 Czech Republic, belonging to the institution); F. HAUBNER; J. A. U. HARDILLO; M. A. HERMSEN; N A. IACOVELLI; R. MAROLDI; S. MATTHEIS; A. MOYA-PLANA; P. NICOLAI; E. ORLANDI; J. THARIAT; A. TRAMA; M. W. M. VAN DEN BREKEL; C. M. L. VAN HERPEN; B. VERILLAUD; E. KINLOCH; L. LICITRA and C. EVEN

Edition

ESMO OPEN, AMSTERDAM, ELSEVIER, 2025, 2059-7029

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30204 Oncology

Country of publisher

Netherlands

Confidentiality degree

is not subject to a state or trade secret

References:

URL

Impact factor

Impact factor: 7.100 in 2023

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.esmoop.2024.104121

UT WoS

001434893900001

EID Scopus

2-s2.0-85218089586

Keywords in English

endoscopic surgery; (neoadjuvant) chemotherapy; radiotherapy; proton therapy; sinonasal carcinomas

Abstract

V originále

The term sinonasal malignancies (SMs) groups together many tumours of variable histology and biological behaviour. This Clinical Practice Guideline (CPG) covers the histotypes included in the fifth edition of the World Health Organization classification of tumours of the nasal cavity, paranasal sinuses and skull base (see Supplementary Table S1, available at https://doi.org/10.1016/j.esmoop.2024.104121) under ‘carcinomas’, ‘adenocarcinomas’ and ‘olfactory neuroblastomas’. Additionally, this CPG covers neuroendocrine carcinomas rising in this area such as small-cell neuroendocrine carcinoma (SCNEC) and large-cell sinonasal neuroendocrine carcinoma (SNEC). Salivary-type malignancies, mesenchymal tumours and mucosal melanoma of the sinonasal tract have been excluded, since dedicated guidelines already exist.

Cite

RESTEGHINI, C.; B. BAUJAT; P. BOSSI; A. FRANCHI; L. DE GABORY; Jana HALÁMKOVÁ; F. HAUBNER; J. A. U. HARDILLO; M. A. HERMSEN; N A. IACOVELLI; R. MAROLDI; S. MATTHEIS; A. MOYA-PLANA; P. NICOLAI; E. ORLANDI; J. THARIAT; A. TRAMA; M. W. M. VAN DEN BREKEL; C. M. L. VAN HERPEN; B. VERILLAUD; E. KINLOCH; L. LICITRA and C. EVEN. Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO OPEN. AMSTERDAM: ELSEVIER, 2025, vol. 10, No 2, p. 1-15. ISSN 2059-7029. Available from: https://dx.doi.org/10.1016/j.esmoop.2024.104121.

@article{2488679,
   author = {Resteghini, C. and Baujat, B. and Bossi, P. and Franchi, A. and de Gabory, L. and Halámková, Jana and Haubner, F. and Hardillo, J. A. U. and Hermsen, M. A. and Iacovelli, N A. and Maroldi, R. and Mattheis, S. and MoyaandPlana, A. and Nicolai, P. and Orlandi, E. and Thariat, J. and Trama, A. and van den Brekel, M. W. M. and van Herpen, C. M. L. and Verillaud, B. and Kinloch, E. and Licitra, L. and Even, C.},
   article_location = {AMSTERDAM},
   article_number = {2},
   doi = {http://dx.doi.org/10.1016/j.esmoop.2024.104121},
   keywords = {endoscopic surgery; (neoadjuvant) chemotherapy; radiotherapy; proton therapy; sinonasal carcinomas},
   language = {eng},
   issn = {2059-7029},
   journal = {ESMO OPEN},
   title = {Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up},
   url = {https://www.sciencedirect.com/science/article/pii/S2059702924018921?via%3Dihub},
   volume = {10},
   year = {2025}
}

TY  - JOUR
ID  - 2488679
AU  - Resteghini, C. - Baujat, B. - Bossi, P. - Franchi, A. - de Gabory, L. - Halámková, Jana - Haubner, F. - Hardillo, J. A. U. - Hermsen, M. A. - Iacovelli, N A. - Maroldi, R. - Mattheis, S. - Moya-Plana, A. - Nicolai, P. - Orlandi, E. - Thariat, J. - Trama, A. - van den Brekel, M. W. M. - van Herpen, C. M. L. - Verillaud, B. - Kinloch, E. - Licitra, L. - Even, C.
PY  - 2025
TI  - Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
JF  - ESMO OPEN
VL  - 10
IS  - 2
SP  - 1-15
EP  - 1-15
PB  - ELSEVIER
SN  - 20597029
KW  - endoscopic surgery
KW  - (neoadjuvant) chemotherapy
KW  - radiotherapy
KW  - proton therapy
KW  - sinonasal carcinomas
UR  - https://www.sciencedirect.com/science/article/pii/S2059702924018921?via%3Dihub
N2  - The term sinonasal malignancies (SMs) groups together many tumours of variable histology and biological behaviour. This Clinical Practice Guideline (CPG) covers the histotypes included in the fifth edition of the World Health Organization classification of tumours of the nasal cavity, paranasal sinuses and skull base (see Supplementary Table S1, available at https://doi.org/10.1016/j.esmoop.2024.104121) under ‘carcinomas’, ‘adenocarcinomas’ and ‘olfactory neuroblastomas’. Additionally, this CPG covers neuroendocrine carcinomas rising in this area such as small-cell neuroendocrine carcinoma (SCNEC) and large-cell sinonasal neuroendocrine carcinoma (SNEC). Salivary-type malignancies, mesenchymal tumours and mucosal melanoma of the sinonasal tract have been excluded, since dedicated guidelines already exist.
ER  -

RESTEGHINI, C.; B. BAUJAT; P. BOSSI; A. FRANCHI; L. DE GABORY; Jana HALÁMKOVÁ; F. HAUBNER; J. A. U. HARDILLO; M. A. HERMSEN; N A. IACOVELLI; R. MAROLDI; S. MATTHEIS; A. MOYA-PLANA; P. NICOLAI; E. ORLANDI; J. THARIAT; A. TRAMA; M. W. M. VAN DEN BREKEL; C. M. L. VAN HERPEN; B. VERILLAUD; E. KINLOCH; L. LICITRA and C. EVEN. Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. \textit{ESMO OPEN}. AMSTERDAM: ELSEVIER, 2025, vol.~10, No~2, p.~1-15. ISSN~2059-7029. Available from: https://dx.doi.org/10.1016/j.esmoop.2024.104121.

Přehled o publikaci